Early VTE prophylaxis in severe traumatic brain injury: A propensity score weighted EAST multicenter study.
Journal
The journal of trauma and acute care surgery
ISSN: 2163-0763
Titre abrégé: J Trauma Acute Care Surg
Pays: United States
ID NLM: 101570622
Informations de publication
Date de publication:
01 07 2023
01 07 2023
Historique:
medline:
23
6
2023
pubmed:
6
4
2023
entrez:
5
4
2023
Statut:
ppublish
Résumé
Patients with traumatic brain injury (TBI) are at high risk of venous thromboembolism events (VTE). We hypothesized that early chemical VTE prophylaxis initiation (≤24 hours of a stable head CT) in severe TBI would reduce VTE without increasing risk of intracranial hemorrhage expansion (ICHE). A retrospective review of adult patients 18 years or older with isolated severe TBI (Abbreviated Injury Scale score, ≥ 3) who were admitted to 24 Level I and Level II trauma centers from January 1, 2014 to December 31 2020 was conducted. Patients were divided into those who did not receive any VTE prophylaxis (NO VTEP), who received VTE prophylaxis ≤24 hours after stable head CT (VTEP ≤24) and who received VTE prophylaxis >24 hours after stable head CT (VTEP>24). Primary outcomes were VTE and ICHE. Covariate balancing propensity score weighting was utilized to balance demographic and clinical characteristics across three groups. Weighted univariate logistic regression models were estimated for VTE and ICHE with patient group as predictor of interest. Of 3,936 patients, 1,784 met inclusion criteria. Incidences of VTE was significantly higher in the VTEP>24 group, with higher incidences of DVT in the group. Higher incidences of ICHE were observed in the VTEP≤24 and VTEP>24 groups. After propensity score weighting, there was a higher risk of VTE in patients in VTEP >24 compared with those in VTEP≤24 (odds ratio, 1.51; 95% confidence interval, 0.69-3.30; p = 0.307), however was not significant. Although, the No VTEP group had decreased odds of having ICHE compared with VTEP≤24 (odds ratio, 0.75; 95% confidence interval, 0.55-1.02, p = 0.070), the result was not statistically significant. In this large multi-center analysis, there were no significant differences in VTE based on timing of initiation of VTE prophylaxis. Patients who never received VTE prophylaxis had decreased odds of ICHE. Further evaluation of VTE prophylaxis in larger randomized studies will be necessary for definitive conclusions. Therapeutic Care Management; Level III.
Sections du résumé
BACKGROUND
Patients with traumatic brain injury (TBI) are at high risk of venous thromboembolism events (VTE). We hypothesized that early chemical VTE prophylaxis initiation (≤24 hours of a stable head CT) in severe TBI would reduce VTE without increasing risk of intracranial hemorrhage expansion (ICHE).
METHODS
A retrospective review of adult patients 18 years or older with isolated severe TBI (Abbreviated Injury Scale score, ≥ 3) who were admitted to 24 Level I and Level II trauma centers from January 1, 2014 to December 31 2020 was conducted. Patients were divided into those who did not receive any VTE prophylaxis (NO VTEP), who received VTE prophylaxis ≤24 hours after stable head CT (VTEP ≤24) and who received VTE prophylaxis >24 hours after stable head CT (VTEP>24). Primary outcomes were VTE and ICHE. Covariate balancing propensity score weighting was utilized to balance demographic and clinical characteristics across three groups. Weighted univariate logistic regression models were estimated for VTE and ICHE with patient group as predictor of interest.
RESULTS
Of 3,936 patients, 1,784 met inclusion criteria. Incidences of VTE was significantly higher in the VTEP>24 group, with higher incidences of DVT in the group. Higher incidences of ICHE were observed in the VTEP≤24 and VTEP>24 groups. After propensity score weighting, there was a higher risk of VTE in patients in VTEP >24 compared with those in VTEP≤24 (odds ratio, 1.51; 95% confidence interval, 0.69-3.30; p = 0.307), however was not significant. Although, the No VTEP group had decreased odds of having ICHE compared with VTEP≤24 (odds ratio, 0.75; 95% confidence interval, 0.55-1.02, p = 0.070), the result was not statistically significant.
CONCLUSION
In this large multi-center analysis, there were no significant differences in VTE based on timing of initiation of VTE prophylaxis. Patients who never received VTE prophylaxis had decreased odds of ICHE. Further evaluation of VTE prophylaxis in larger randomized studies will be necessary for definitive conclusions.
LEVEL OF EVIDENCE
Therapeutic Care Management; Level III.
Identifiants
pubmed: 37017458
doi: 10.1097/TA.0000000000003985
pii: 01586154-202307000-00014
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
94-104Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Kim L, Holena D, Schuster J, Sims C, Levine J, Pascual JL. Early initiation of prophylactic heparin in severe traumatic brain injury is associated with accelerated improvement on brain imaging. J Emerg Trauma Shock . 2014;141–147.
Peterson AB, Thomas KE. Incidence of nonfatal traumatic brain injury–related hospitalizations—United States, 2018. MMWR Morb Mortal Wkly Rep . 2021;48:1664–1668.
Scales DC, Riva-Cambrin J, Wells D, Athaide V, Granton JT, Detsky AS. Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis. Crit Care . 2010;14:R72.
Hubbard WB, Dong JF, Cruz MA, Rumbaut RE. Links between thrombosis and inflammation in traumatic brain injury. Thromb Res . 2021;198:62–71.
Skrifvars MB, Bailey M, Presneill J, French C, Nichol A, Little L; EPO-TBI investigators and the ANZICS clinical trials group. Venous thromboembolic events in critically ill traumatic brain injury patients. Intensive Care Med . 2017;3:419–428.
American College of Surgeons Committee on Trauma: ACS TQIP Best Practices in the Management of Traumatic Brain Injury 2015 Available from: https://www.facs.org/media/mkej5u3b/tbi_guidelines.pdf . Accessed January 2022.
Jamjoom AA, Jamjoom AB. Safety and efficacy of early pharmacological thromboprophylaxis in traumatic brain injury: systematic review and meta-analysis. J Neurotrauma . 2013;30:503–511.
Guidelines for the Management of Severe TBI . 4th ed.. [Available from: https://braintrauma.org/guidelines/guidelines-for-the-management-of-severe-tbi-4th-ed . Accessed January 2022.
NICE Guideline. Venous thromboembolism in over 16 s: reducing the risk of hospital-acquired deep venous thrombosis or pulmonary embolism 2018 [Available from: https://www.nice.org.uk/guidance/ng89/chapter/Recommendations#interventions-for-people-with-major-trauma . Accessed January 2022.
Ley EJ, Brown CVR, Moore EE, Sava JA, Peck K, Ciesla DJ, et al. Updated guidelines to reduce venous thromboembolism in trauma patients: a Western Trauma Association critical decisions algorithm. J Trauma Acute Care Surg . 2020;89:971–981.
Rappold JF, Sheppard FR, Carmichael Ii SP, Cuschieri J, Ley E, Rangel E, et al. Venous thromboembolism prophylaxis in the trauma intensive care unit: an American Association for the Surgery of Trauma critical care committee clinical consensus document. Trauma Surg Acute Care Open . 2021;6:e000643.
Yorkgitis BK, Berndtson AE, Cross A, Kennedy R, Kochuba MP, Tignanelli C, et al. American Association for the Surgery of Trauma/American College of Surgeons—Committee on Trauma Clinical Protocol for inpatient venous thromboembolism prophylaxis after trauma. J Trauma Acute Care Surg . 2022;92:597–604.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol . 2008;61:344–349.
Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med . 2009;28:3083–3107.
WeightIt: Weighting for Covariate Balance in Observational Studies. [Available from: https://cran.r-project.org/web/packages/WeightIt/index.html . Accessed July 2022.
Byrne JP, Mason SA, Gomez D, Hoeft C, Subacius H, Xiong W, et al. Timing of pharmacologic venous thromboembolism prophylaxis in severe traumatic brain injury: a propensity-matched cohort study. J Am Coll Surg . 2016;223:621–631.
Reiff DA, Haricharan RN, Bullington NM, Griffin RL, McGwin G Jr., Rue LW 3rd. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma . 2009;66:1436–1440.
Prabhakaran KGS, Lombardo G, Latifi R. Venous thromboembolism in geriatric trauma patients—risk factors and associated outcomes. J Surg Res . 2020;327–333.
Tian Y, Salsbery B, Wang M, Yuan H, Yang J, Zhao Z, et al. Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury. Blood . 2015;125:2151–2159.
Samuels JM, Moore EE, Silliman CC, Banerjee A, Cohen MJ, Ghasabyan A, Chandler J, Coleman JR, Sauaia A. Severe traumatic brain injury is associated with a unique coagulopathy phenotype. J Trauma Acute Care Surg . 2019;86:686–693.
Patel NY, Hoyt DB, Nakaji P, Marshall L, Holbrook T, Coimbra R. Traumatic brain injury: patterns of failure of nonoperative management. J Trauma . 2000;48:367–375.
Alahmadi H, Vachhrajani S, Cusimano MD. The natural history of brain contusion: an analysis of radiological and clinical progression. J Neurosurg . 2010;112:1139–1145.
Cepeda S, Gómez PA, Castaño-Leon AM, Martínez-Pérez R, Munarriz PM, Lagares A. Traumatic intracerebral hemorrhage: risk factors associated with progression. J Neurotrauma . 2015;32:1246–1253.
Chang EF, Meeker M, Holland MC. Acute traumatic intraparenchymal hemorrhage: risk factors for progression in the early post-injury period. Neurosurgery . 2007;61:222–230.
Carnevale JA, Segar DJ, Powers AY, Shah M, Doberstein C, Drapcho B, et al. Blossoming contusions: identifying factors contributing to the expansion of traumatic intracerebral hemorrhage. J Neurosurg . 2018;129:1305–1316.
Oertel MKD, McArthur D, et al. Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury. J Neurosurg . 2002;109e116.
Byrne JP, Witiw CD, Schuster JM, Pascual JL, Cannon JW, Martin ND, et al. Association of venous thromboembolism prophylaxis after neurosurgical intervention for traumatic brain injury with thromboembolic complications, repeated neurosurgery, and mortality. JAMA Surg . 2022;157:e215794.
Nathens AB, McMurray MK, Cuschieri J, Durr EA, Moore EE, Bankey PE, et al. The practice of venous thromboembolism prophylaxis in the major trauma patient. J Trauma . 2007;62:557–562.
Saadeh Y, Gohil K, Bill C, Smith C, Morrison C, Mosher B, et al. Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT. J Trauma Acute Care Surg . 2012;73:426–430.
Nickele CMKT, Medow JE. Safety of a DVT chemoprophylaxis protocol following traumatic brain injury: a single center quality improvement initiative. Neurocrit Care . 2013;18:184–192.
Farooqui A, Hiser B, Barnes SL, Litofsky NS. Safety and efficacy of early thromboembolism chemoprophylaxis after intracranial hemorrhage from traumatic brain injury. J Neurosurg . 2013;119:1576–1582.
Scudday T, Brasel K, Webb T, Codner P, Somberg L, Weigelt J, et al. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury. J Am Coll Surg . 2011;213:148–153.
Zhang Z. Missing data imputation: focusing on single imputation. Ann Transl Med . 2016;4:9.